Unveiling the role of tumor reactive stroma in cholangiocarcinoma: an opportunity for new therapeutic strategies.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Translational gastrointestinal cancer

• Publication date

  2013-07-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3978/j.issn.2224-4778.2013.04.02PMID 28989865PMCID PMC5627657
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Platelet‐derived growth factor‐D and Rho GTPases regulate recruitment of cancer‐associated fibroblasts in cholangiocarcinoma

  2013influential reference
• Molecular aspects of cancer cell resistance to chemotherapy.

  2013cited by this paper
• Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma.

  2013cited by this paper
• Vascular endothelial growth factor-C and -D are involved in lymphangiogenesis in mouse unilateral ureteral obstruction.

  2013cited by this paper
• Classification, diagnosis, and management of cholangiocarcinoma.

  2013cited by this paper
• Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO.

  2012cited by this paper
• Neuropilin-1 stimulates tumor growth by increasing fibronectin fibril assembly in the tumor microenvironment.

  2012cited by this paper
• The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma

  2012influential reference
• Cholangiocarcinoma pathogenesis: Role of the tumor microenvironment.

  2012cited by this paper
• The prognosis of perihilar cholangiocarcinoma after radical treatments

  2012cited by this paper
• Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.

  2012cited by this paper
• Tumor Lymphangiogenesis as a Potential Therapeutic Target

  2012cited by this paper
• Role of the stromal-derived factor-1 (SDF-1)-CXCR4 axis in the interaction between hepatic stellate cells and cholangiocarcinoma.

  2012cited by this paper
• Cholangiocarcinomas can originate from hepatocytes in mice.

  2012cited by this paper
• Blocking Fibroblast Growth Factor Receptor Signaling Inhibits Tumor Growth, Lymphangiogenesis, and Metastasis

  2012influential reference
• Predictors of pretransplant dropout and posttransplant recurrence in patients with perihilar cholangiocarcinoma

  2012cited by this paper
• Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes

  2012cited by this paper
• Periostin, a matrix protein, has potential as a novel serodiagnostic marker for cholangiocarcinoma.

  2011cited by this paper
• Epithelial–Mesenchymal Interactions in Biliary Diseases

  2011cited by this paper
• Development of molecularly targeted therapies in biliary tract cancers: Reassessing the challenges and opportunities

  2011cited by this paper
• The lymphatic vasculature in disease

  2011cited by this paper
• Role of tumor-associated macrophages in the progression of hepatocellular carcinoma

  2011cited by this paper
• Ovarian cancer-associated fibroblasts contribute to epithelial ovarian carcinoma metastasis by promoting angiogenesis, lymphangiogenesis and tumor cell invasion.

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Tumor‐secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts

  2011cited by this paper
• Targeting PDGFR‐β in Cholangiocarcinoma

  2011cited by this paper
• The Role of Tumor Stroma in Cancer Progression and Prognosis: Emphasis on Carcinoma-Associated Fibroblasts and Non-small Cell Lung Cancer

  2011cited by this paper
• Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the "Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease.

  2011cited by this paper
• Hepatic Stellate Cells Accelerate the Malignant Behavior of Cholangiocarcinoma Cells

  2011cited by this paper
• Is it the end of the line for the EMT?

  2011cited by this paper
• Tumour macrophages as potential targets of bisphosphonates

  2011cited by this paper
• Hypoxia inducible factor expression in intrahepatic cholangiocarcinoma.

  2011cited by this paper
• Molecular mechanisms of lymphangiogenesis in development and cancer.

  2011cited by this paper
• Nuclear expression of S100A4 calcium‐binding protein increases cholangiocarcinoma invasiveness and metastasization

  2011cited by this paper
• Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours.

  2011cited by this paper
• Myofibroblast‐derived PDGF‐BB promotes hedgehog survival signaling in cholangiocarcinoma cells

  2011cited by this paper
• Cancer surveillance in patients with primary sclerosing cholangitis

  2011cited by this paper
• Mechanisms linking pathogens-associated inflammation and cancer.

  2011cited by this paper
• Risk factors for cholangiocarcinoma

  2011cited by this paper
• Neuropilin-2 mediates VEGF-C–induced lymphatic sprouting together with VEGFR3

  2010cited by this paper
• Epithelial-mesenchymal transition induced by transforming growth factor-{beta}1/Snail activation aggravates invasive growth of cholangiocarcinoma.

  2010cited by this paper
• Macrophage diversity enhances tumor progression and metastasis.

  2010influential reference
• Cholangiocarcinoma: update and future perspectives.

  2010cited by this paper
• Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm

  2010cited by this paper
• Phase 1‐2 trial of PTK787/ZK222584 combined with intravenous doxorubicin for treatment of patients with advanced hepatocellular carcinoma

  2010cited by this paper
• Intra-hepatic and extra-hepatic cholangiocarcinoma: New insight into epidemiology and risk factors.

  2010cited by this paper
• Mammalian target of rapamycin regulates vascular endothelial growth factor–dependent liver cyst growth in polycystin‐2–defective mice

  2010cited by this paper
• Recent advances in the regulation of cholangiocarcinoma growth.

  2010cited by this paper
• Interleukin 6 mediated recruitment of mesenchymal stem cells to the hypoxic tumor milieu.

  2010cited by this paper
• Assembly of fibronectin extracellular matrix.

  2010cited by this paper
• Hypoxia: a link between fibrogenesis, angiogenesis, and carcinogenesis in liver disease.

  2010cited by this paper
• The role of macrophages and mast cells in lymphangiogenesis and angiogenesis in cervical carcinogenesis.

  2010cited by this paper
• Phase I and pharmacological study of the broad-spectrum tyrosine kinase inhibitor JNJ-26483327 in patients with advanced solid tumours

  2010cited by this paper
• Tumorigenesis and Neoplastic Progression Stromal Fibroblasts in Colorectal Liver Metastases Originate From Resident Fibroblasts and Generate an Inflammatory Microenvironment

  2010cited by this paper
• Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.

  2010cited by this paper
• Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma

  2010cited by this paper
• Tissue invasive macrophage density is correlated with prognosis in cholangiocarcinoma.

  2010cited by this paper
• Alpha-smooth muscle actin-positive fibroblasts promote biliary cell proliferation and correlate with poor survival in cholangiocarcinoma.

  2009cited by this paper
• Adult Stromal Cells Derived from Human Adipose Tissue Provoke Pancreatic Cancer Cell Death both In Vitro and In Vivo

  2009cited by this paper
• Inhibition of Cyclooxygenase‐2 Suppresses Lymph Node Metastasis via VEGF‐C

  2009cited by this paper
• Overexpression of PD-L1 Significantly Associates with Tumor Aggressiveness and Postoperative Recurrence in Human Hepatocellular Carcinoma

  2009cited by this paper
• Cancer-associated fibroblasts and tumor growth--bystanders turning into key players.

  2009cited by this paper
• Role of macrophages in tumour progression.

  2009influential reference
• Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer

  2009cited by this paper
• Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system

  2009cited by this paper
• Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway

  2009cited by this paper
• Desmoplasia of pancreatic ductal adenocarcinoma.

  2009cited by this paper
• Photodynamic therapy is associated with an improvement in survival in patients with irresectable hilar cholangiocarcinoma.

  2009cited by this paper
• Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1

  2009cited by this paper
• Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

  2009cited by this paper
• Endothelin inhibits cholangiocarcinoma growth by a decrease in the vascular endothelial growth factor expression

  2009cited by this paper
• Hypoxia-inducible factors in stem cells and cancer

  2009cited by this paper
• On the origin of cancer-associated fibroblasts

  2009cited by this paper
• The basics of epithelial-mesenchymal transition.

  2009cited by this paper
• Expression and clinical implication of HIF-1α and VEGF-C in non-small cell lung cancer

  2008cited by this paper
• Vascular endothelial growth factor receptor 2 mediates macrophage infiltration into orthotopic pancreatic tumors in mice.

  2008cited by this paper
• Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment

  2008cited by this paper
• Lymphatic spread is related to VEGF-C expression and D2-40-positive myofibroblasts in intrahepatic cholangiocarcinoma

  2008cited by this paper
• Targeting tumor stroma.

  2008cited by this paper
• NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α

  2008cited by this paper
• Expression of Hypoxia-Inducible Factor (HIF)-1α and Vascular Endothelial Growth Factor (VEGF)-D As Outcome Predictors in Resected Esophageal Squamous Cell Carcinoma

  2008cited by this paper
• Hypoxia-induced epithelial VEGF-C/VEGFR-3 upregulation in carcinoma cell lines.

  2008influential reference
• Diagnosis and management of cholangiocarcinoma

  2008cited by this paper
• Hypoxia inducible factor-alpha expression correlates with vascular endothelial growth factor-C expression and lymphangiogenesis/angiogenesis in oral squamous cell carcinoma.

  2008cited by this paper
• Tumor stroma as a target in cancer.

  2008cited by this paper
• Hypoxia Inducible Factor-1alpha Expression Correlates with Vascular Endothelial Growth Factor-C Expression and Lymphangiogenesis/Angiogenesis in Oral Squamous Cell Carcinoma

  2008cited by this paper
• Cholangiocarcinoma: Thirty-one-Year Experience With 564 Patients at a Single Institution

  2007cited by this paper
• Pancreatic cancer-associated stroma production.

  2007cited by this paper
• Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via reduction of lymphangiogenesis.

  2007cited by this paper
• Rapamycin, a specific inhibitor of the mammalian target of rapamycin, suppresses lymphangiogenesis and lymphatic metastasis

  2007cited by this paper
• Anti‐VEGF‐A therapy reduces lymphatic vessel density and expression of VEGFR‐3 in an orthotopic breast tumor model

  2007cited by this paper
• The Clinicopathologic Significance of the Expression of Vascular Endothelial Growth Factor-C in Intrahepatic Cholangiocarcinoma

  2006cited by this paper
• Distinct role of macrophages in different tumor microenvironments.

  2006influential reference
• Stromal Fibroblasts in Cancer: A Novel Tumor-Promoting Cell Type

  2006cited by this paper
• p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance.

  2006cited by this paper
• Fibroblasts in cancer

  2006influential reference
• Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis.

  2006influential reference
• Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines.

  2006cited by this paper
• Cholangiocarcinoma: modern advances in understanding a deadly old disease.

  2006cited by this paper
• Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake.

  2006cited by this paper

• Cholangiocarcinoma 2026: status quo, unmet needs and priorities

  2025cites this paper
• Cancer-Associated Fibroblasts in Intrahepatic Cholangiocarcinoma: Insights into Origins, Heterogeneity, Lymphangiogenesis, and Peritoneal Metastasis.

  2024cites this paper
• Cancer-on-chip: a 3D model for the study of the tumor microenvironment

  2023cites this paper
• Cholangiocarcinoma tumor microenvironment highlighting fibrosis and matrix components

  2023cites this paper
• Heterogeneity, crosstalk and targeting of cancer associated fibroblasts in cholangiocarcinoma.

  2023cites this paper
• Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma progression and therapeutic resistance.

  2022cites this paper
• Immunotherapy in cholangiocarcinoma: From concept to clinical trials

  2021cites this paper
• Tumor Lymphatic Interactions Induce CXCR2-CXCL5 Axis and Alter Cellular Metabolism and Lymphangiogenic Pathways to Promote Cholangiocarcinoma

  2021cites this paper
• Targeting lymphangiogenesis and lymph node metastasis in liver cancer.

  2021influential citation
• The Tumor Environment: Cholangiocarcinoma-Associated Fibroblasts and Beyond

  2021cites this paper
• New insights on the role of vascular endothelial growth factor in biliary pathophysiology

  2021cites this paper
• Tumor Infiltrating Neutrophils Are Frequently Found in Adenocarcinomas of the Biliary Tract and Their Precursor Lesions with Possible Impact on Prognosis

  2021cites this paper
• Role of Chemokines in the Biology of Cholangiocarcinoma

  2020cites this paper
• Evolution of the Experimental Models of Cholangiocarcinoma

  2020cites this paper
• Mass spectrometry-based analysis of formalin-fixed, paraffin-embedded distal cholangiocarcinoma identifies stromal thrombospondin-2 as a potential prognostic marker

  2020cites this paper
• Tumor microenvironment in primary liver tumors: A challenging role of natural killer cells

  2020cites this paper
• World Journal of Gastroenterology Treatment for inflammatory using literature-related discovery and in primary liver tumors: A challenging role of natural killer cells

  2020cites this paper
• Chemokines in the cholangiocarcinoma

  2020cites this paper
• Role of Cancer Stem Cells in Cholangiocarcinoma and Therapeutic Implications

  2019influential citation
• Inflammation and Progression of Cholangiocarcinoma: Role of Angiogenic and Lymphangiogenic Mechanisms

  2019influential citation
• Recreating Tumour Complexity in a Dish: Organoid Models to Study Liver Cancer Cells and their Extracellular Environment

  2019influential citation
• Deregulated Lysophosphatidic Acid Metabolism and Signaling in Liver Cancer

  2019cites this paper
• The Role of Stroma in Cholangiocarcinoma: The Intriguing Interplay between Fibroblastic Component, Immune Cell Subsets and Tumor Epithelium

  2018cites this paper
• Molecular mechanisms of cholangiocarcinoma progression: emphasizing the role of tumor-stroma interactions

  2018cites this paper
• Clinical Implications of Cytotoxic T Lymphocyte Antigen-4 Expression on Tumor Cells and Tumor-Infiltrating Lymphocytes in Extrahepatic Bile Duct Cancer Patients Undergoing Surgery Plus Adjuvant Chemoradiotherapy

  2017cites this paper
• Transforming Growth Factors α and β Are Essential for Modeling Cholangiocarcinoma Desmoplasia and Progression in a Three-Dimensional Organotypic Culture Model.

  2017cites this paper
• Molecular Mechanisms Driving Cholangiocarcinoma Invasiveness: An Overview.

  2017cites this paper
• Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness

  2017cites this paper
• Autocrine and Paracrine Mechanisms Promoting Chemoresistance in Cholangiocarcinoma

  2017influential citation
• The deleterious interplay between tumor epithelia and stroma in cholangiocarcinoma.

  2017cites this paper
• Bisphosphonates as potential adjuvants for patients with cancers of the digestive system.

  2016cites this paper
• Nanocarrier-Based Anticancer Therapies with the Focus on Strategies for Targeting the Tumor Microenvironment

  2016cites this paper
• Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma?

  2015influential citation
• Pathogenesis and Therapeutic Targets of Cholangiocarcinoma

  2015cites this paper
• Targeted Deletion of ER Chaperone GRP94 in the Liver Results in Injury, Repopulation of GRP94-Positive Hepatocytes, and Spontaneous Hepatocellular Carcinoma Development in Aged Mice

  2014cites this paper
• Tumor microenvironment and nanotherapeutics.

  2013influential citation